Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission.
about
Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Consolidation therapy with dec ...... d leukemia in first remission.
@en
Consolidation therapy with dec ...... d leukemia in first remission.
@nl
type
label
Consolidation therapy with dec ...... d leukemia in first remission.
@en
Consolidation therapy with dec ...... d leukemia in first remission.
@nl
prefLabel
Consolidation therapy with dec ...... d leukemia in first remission.
@en
Consolidation therapy with dec ...... d leukemia in first remission.
@nl
P2093
P2860
P1433
P1476
Consolidation therapy with dec ...... d leukemia in first remission.
@en
P2093
Ai-Ning Sun
Hui-Ying Qiu
Su-Ning Chen
Wei-Yang Li
Zheng-Zheng Fu
P2860
P356
10.1080/10428194.2017.1390235
P577
2017-10-18T00:00:00Z